Loading clinical trials...
Loading clinical trials...
Restoring Vasodilator Actions of Insulin in Patients With Type 2 Diabetes
The purpose of the present study is to determine the effects of increased walking and lower body heating on leg vascular function in patients with type 2 diabetes (T2D).
The notion that habitual aerobic exercise increases insulin-induced vasodilation is largely founded on rodent studies, hence the urgent need for human studies, especially in patients with type 2 diabetes (T2D). For example, it remains unknown if increased walking, the most common form of physical activity, enhances skeletal muscle vasodilator actions of insulin in T2D. In addition, the molecular mechanisms by which exercise improves vasoreactivity to insulin have not been examined in humans. The investigators propose that in T2D patients who are sedentary (i.e., the vast majority), increased leg blood flow with walking or local heating signifies a vital strategy to correct vascular insulin resistance. This study will establish whether increased physical activity and associated hemodynamic forces (e.g., shear stress) are a direct form of vascular medicine in humans.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
Yes
University of Missouri
Columbia, Missouri, United States
Start Date
December 4, 2017
Primary Completion Date
March 10, 2022
Completion Date
March 10, 2022
Last Updated
April 4, 2024
99
ACTUAL participants
Walking: Intervention arm in diabetics
BEHAVIORAL
Walking: No intervention in diabetics
OTHER
Walking: Healthy cohort as reference controls
OTHER
Lower body heating: Intervention arm in healthy subjects
BEHAVIORAL
Lower body heating: Intervention arm in diabetics
BEHAVIORAL
Lower body heating: Healthy cohort as reference controls
OTHER
Lead Sponsor
University of Missouri-Columbia
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT01143454